1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > Radiotherapy Global Market Forecast (2014-2020)

Radiotherapy Global Market Forecast (2014-2020)

  • February 2015
  • -
  • Hoovers Research

Hoovers Research analysis is one of the most accurate studies performed using the combinational analytical tools. The report contains up to date financial data derived from varied research sources to present unique and reliable analysis. Assessment of major trends with potential impact on the market during the next five years, including a deep dive analysis of market segmentation which comprises of sub markets, regional and country level analysis.

This report analyzes the global markets for “Radiotherapy“. The report provides the standard and the tailored research methodology approach. The market overview offers in depth analysis for the regional and country level analysis, for instance North America (U.S., and Canada), Europe (Germany, France, Italy, U.K. and Spain), Asia-Pacific (China, Japan, India, South Korea and Rest of APAC) and Rest of the World (Middle East, Africa and Latin America). Annual estimations and forecasts are provided from the year 2012 to 2020 for each given segments and sub segments. Market data derived from the authenticated and reliable sources subjected to validation from the industry experts. The report also analyzes the market by discussing market dynamics such as drivers, constraints, opportunities, threats, challenges and other market trends.
Competitive landscaping provides the recent activities performed by the active players in the market. Activities such as product launch, agreements, joint ventures, partnerships, acquisitions and mergers, other activities.

This report provides:
- Market forecasts for a minimum of 5 years of all the mentioned segments, sub segments and the regional markets
- Identifying market dynamics (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Regional and country level market analysis
- Competitive landscaping mapping the key common trends
- Company profiling covering the financials, recent activities and the future strategies
- Supply chain trends mapping the recent advancements
- Market share assessments of the top players along with strategic recommendations for the new entrants

Table Of Contents

Radiotherapy Global Market Forecast (2014-2020)
1 Introduction
1.1 Scope of the Report
1.2 Report Description
1.3 Research Methodology
1.4 Research Sources
1.4.1 Secondary Research
1.4.2 Primary Research
1.4.3 Assumptions
1.5 List of Abbreviations

2 Executive Summary

3 Market Analysis
3.1 Market Segmentation
3.2 Market Size Estimation
3.3 Market Drivers
3.3.1 Strong Network of the major players
3.3.2 Wide range of product offerings
3.3.3 Increasing usage of Chocolate as a Functional Food
3.4 Market Constraints
3.4.1 Supply Dependency On West African Countries For Cocoa
3.4.2 Sluggish growth in Developed regions
3.4.3 Rapidly changing end user preferences

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Radiotherapy Market by Product Type
5.1 Non-Ionizing Radiation
5.2 Ionizing Radiation
5.3 Particle Radiation
5.4 Electron Beams
5.5 Proton Beams
5.6 Neutron Beams
5.7 Carbon Ions
5.8 Alpha and Beta Particles
5.9 Photon Radiations
5.10 Gamma Rays
5.11 X-rays

6 Radiotherapy Market by Technology
6.1 Intensity Modulated Radiation Therapy (IMRT)
6.2 3-D Conformal Radiotherapy (3D CRT)
6.3 Proton Beam Therapy
6.4 Stereotactic Technology
6.5 Tomotherapy
6.6 Adaptive Radiation Therapy
6.7 Systemic Radiation Therapy

7 Radiotherapy Market by Application
7.1 Lung Cancer
7.2 Colorectal Cancer
7.3 Prostate Cancer
7.4 Breast Cancer
7.5 Head and Neck Cancer
7.6 Brain Cancer
7.7 Spine Cancer
7.8 Cervical Cancer

8 Geographical Segmentation
8.1 North America
8.1.1 US
8.1.2 Canada
8.2 Europe
8.2.1 Germany
8.2.2 France
8.2.3 Italy
8.2.4 UK
8.2.5 Spain
8.3 Asia Pacific
8.3.1 Japan
8.3.2 China
8.3.3 India
8.3.4 Australia
8.3.5 Newzealand
8.3.6 Rest of Asia Pacific
8.4 RoW
8.4.1 Latin America
8.4.2 Middle East
8.4.3 Africa
8.4.4 Others

9 Vendor Landscaping
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions and Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies

10 Company Profiles
10.1 Varian Medical Systems
10.1.1 Business Overview
10.1.2 SWOT Analysis
10.1.3 Financial Overview
10.1.4 Strategy
10.1.5 Key Activities
10.2 Siemens Healthcare
10.3 Nordion, Inc
10.4 IBA Group
10.5 GE Healthcare
10.6 Covidien, Plc
10.7 Cardinal Health, Inc.
10.8 Accuray, Inc.
10.9 ANSTO
10.10 C. R. Bard, Inc.
11 Appendix
12 Disclaimer

List of Exhibits
Table 1 Global Radiotherapy Market Analysis, by Region, 2013-2020 ($MN)
Table 2 Global Radiotherapy Market Analysis, by Product, 2013-2020 ($MN)
Table 3 Global Radiotherapy Market Analysis, by Non-Ionizing Radiation, 2013-2020 ($MN)
Table 4 Global Radiotherapy Market Analysis, by Ionizing Radiation, 2013-2020 ($MN)
Table 5 Global Radiotherapy Market Analysis, by Particle Radiation, 2013-2020 ($MN)
Table 6 Global Radiotherapy Market Analysis, by Electron Beams, 2013-2020 ($MN)
Table 7 Global Radiotherapy Market Analysis, by Proton Beams, 2013-2020 ($MN)
Table 8 Global Radiotherapy Market Analysis, by Neutron Beams, 2013-2020 ($MN)
Table 9 Global Radiotherapy Market Analysis, by Carbon Ions, 2013-2020 ($MN)
Table 10 Global Radiotherapy Market Analysis, by Alpha and Beta Particles, 2013-2020 ($MN)
Table 11 Global Radiotherapy Market Analysis, by Photon Radiations, 2013-2020 ($MN)
Table 12 Global Radiotherapy Market Analysis, by Gamma Rays, 2013-2020 ($MN)
Table 13 Global Radiotherapy Market Analysis, by X-rays, 2013-2020 ($MN)
Table 14 Global Radiotherapy Market Analysis, by Technology, 2013-2020 ($MN)
Table 15 Global Radiotherapy Market Analysis, by Intensity Modulated Radiation Therapy (IMRT), 2013-2020 ($MN)
Table 16 Global Radiotherapy Market Analysis, by 3-D Conformal Radiotherapy (3D CRT), 2013-2020 ($MN)
Table 17 Global Radiotherapy Market Analysis, by Proton Beam Therapy, 2013-2020 ($MN)
Table 18 Global Radiotherapy Market Analysis, by Stereotactic Technology, 2013-2020 ($MN)
Table 19 Global Radiotherapy Market Analysis, by Tomotherapy, 2013-2020 ($MN)
Table 20 Global Radiotherapy Market Analysis, by Adaptive Radiation Therapy, 2013-2020 ($MN)
Table 21 Global Radiotherapy Market Analysis, by Systemic Radiation Therapy, 2013-2020 ($MN)
Table 22 Global Radiotherapy Market Analysis, by Application, 2013-2020 ($MN)
Table 23 Global Radiotherapy Market Analysis, by Lung Cancer, 2013-2020 ($MN)
Table 24 Global Radiotherapy Market Analysis, by Colorectal Cancer, 2013-2020 ($MN)
Table 25 Global Radiotherapy Market Analysis, by Prostate Cancer, 2013-2020 ($MN)
Table 26 Global Radiotherapy Market Analysis, by Breast Cancer, 2013-2020 ($MN)
Table 27 Global Radiotherapy Market Analysis, by Head and Neck Cancer, 2013-2020 ($MN)
Table 28 Global Radiotherapy Market Analysis, by Brain Cancer, 2013-2020 ($MN)
Table 29 Global Radiotherapy Market Analysis, by Spine Cancer, 2013-2020 ($MN)
Table 30 Global Radiotherapy Market Analysis, by Cervical Cancer, 2013-2020 ($MN)
Table 31 North America Radiotherapy Market Analysis, by Region, 2013-2020 ($MN)
Table 32 North America Radiotherapy Market Analysis, by Product, 2013-2020 ($MN)
Table 33 North America Radiotherapy Market Analysis, by Non-Ionizing Radiation, 2013-2020 ($MN)
Table 34 North America Radiotherapy Market Analysis, by Ionizing Radiation, 2013-2020 ($MN)
Table 35 North America Radiotherapy Market Analysis, by Particle Radiation, 2013-2020 ($MN)
Table 36 North America Radiotherapy Market Analysis, by Electron Beams, 2013-2020 ($MN)
Table 37 North America Radiotherapy Market Analysis, by Proton Beams, 2013-2020 ($MN)
Table 38 North America Radiotherapy Market Analysis, by Neutron Beams, 2013-2020 ($MN)
Table 39 North America Radiotherapy Market Analysis, by Carbon Ions, 2013-2020 ($MN)
Table 40 North America Radiotherapy Market Analysis, by Alpha and Beta Particles, 2013-2020 ($MN)
Table 41 North America Radiotherapy Market Analysis, by Photon Radiations, 2013-2020 ($MN)
Table 42 North America Radiotherapy Market Analysis, by Gamma Rays, 2013-2020 ($MN)
Table 43 North America Radiotherapy Market Analysis, by X-rays, 2013-2020 ($MN)
Table 44 North America Radiotherapy Market Analysis, by Technology, 2013-2020 ($MN)
Table 45 North America Radiotherapy Market Analysis, by Intensity Modulated Radiation Therapy (IMRT), 2013-2020 ($MN)
Table 46 North America Radiotherapy Market Analysis, by 3-D Conformal Radiotherapy (3D CRT), 2013-2020 ($MN)
Table 47 North America Radiotherapy Market Analysis, by Proton Beam Therapy, 2013-2020 ($MN)
Table 48 North America Radiotherapy Market Analysis, by Stereotactic Technology, 2013-2020 ($MN)
Table 49 North America Radiotherapy Market Analysis, by Tomotherapy, 2013-2020 ($MN)
Table 50 North America Radiotherapy Market Analysis, by Adaptive Radiation Therapy, 2013-2020 ($MN)
Table 51 North America Radiotherapy Market Analysis, by Systemic Radiation Therapy, 2013-2020 ($MN)
Table 52 North America Radiotherapy Market Analysis, by Application, 2013-2020 ($MN)
Table 53 North America Radiotherapy Market Analysis, by Lung Cancer, 2013-2020 ($MN)
Table 54 North America Radiotherapy Market Analysis, by Colorectal Cancer, 2013-2020 ($MN)
Table 55 North America Radiotherapy Market Analysis, by Prostate Cancer, 2013-2020 ($MN)
Table 56 North America Radiotherapy Market Analysis, by Breast Cancer, 2013-2020 ($MN)
Table 57 North America Radiotherapy Market Analysis, by Head and Neck Cancer, 2013-2020 ($MN)
Table 58 North America Radiotherapy Market Analysis, by Brain Cancer, 2013-2020 ($MN)
Table 59 North America Radiotherapy Market Analysis, by Spine Cancer, 2013-2020 ($MN)
Table 60 North America Radiotherapy Market Analysis, by Cervical Cancer, 2013-2020 ($MN)
Table 61 Europe Radiotherapy Market Analysis, by Region, 2013-2020 ($MN)
Table 62 Europe Radiotherapy Market Analysis, by Product, 2013-2020 ($MN)
Table 63 Europe Radiotherapy Market Analysis, by Non-Ionizing Radiation, 2013-2020 ($MN)
Table 64 Europe Radiotherapy Market Analysis, by Ionizing Radiation, 2013-2020 ($MN)
Table 65 Europe Radiotherapy Market Analysis, by Particle Radiation, 2013-2020 ($MN)
Table 66 Europe Radiotherapy Market Analysis, by Electron Beams, 2013-2020 ($MN)
Table 67 Europe Radiotherapy Market Analysis, by Proton Beams, 2013-2020 ($MN)
Table 68 Europe Radiotherapy Market Analysis, by Neutron Beams, 2013-2020 ($MN)
Table 69 Europe Radiotherapy Market Analysis, by Carbon Ions, 2013-2020 ($MN)
Table 70 Europe Radiotherapy Market Analysis, by Alpha and Beta Particles, 2013-2020 ($MN)
Table 71 Europe Radiotherapy Market Analysis, by Photon Radiations, 2013-2020 ($MN)
Table 72 Europe Radiotherapy Market Analysis, by Gamma Rays, 2013-2020 ($MN)
Table 73 Europe Radiotherapy Market Analysis, by X-rays, 2013-2020 ($MN)
Table 74 Europe Radiotherapy Market Analysis, by Technology, 2013-2020 ($MN)
Table 75 Europe Radiotherapy Market Analysis, by Intensity Modulated Radiation Therapy (IMRT), 2013-2020 ($MN)
Table 76 Europe Radiotherapy Market Analysis, by 3-D Conformal Radiotherapy (3D CRT), 2013-2020 ($MN)
Table 77 Europe Radiotherapy Market Analysis, by Proton Beam Therapy, 2013-2020 ($MN)
Table 78 Europe Radiotherapy Market Analysis, by Stereotactic Technology, 2013-2020 ($MN)
Table 79 Europe Radiotherapy Market Analysis, by Tomotherapy, 2013-2020 ($MN)
Table 80 Europe Radiotherapy Market Analysis, by Adaptive Radiation Therapy, 2013-2020 ($MN)
Table 81 Europe Radiotherapy Market Analysis, by Systemic Radiation Therapy, 2013-2020 ($MN)
Table 82 Europe Radiotherapy Market Analysis, by Application, 2013-2020 ($MN)
Table 83 Europe Radiotherapy Market Analysis, by Lung Cancer, 2013-2020 ($MN)
Table 84 Europe Radiotherapy Market Analysis, by Colorectal Cancer, 2013-2020 ($MN)
Table 85 Europe Radiotherapy Market Analysis, by Prostate Cancer, 2013-2020 ($MN)
Table 86 Europe Radiotherapy Market Analysis, by Breast Cancer, 2013-2020 ($MN)
Table 87 Europe Radiotherapy Market Analysis, by Head and Neck Cancer, 2013-2020 ($MN)
Table 88 Europe Radiotherapy Market Analysis, by Brain Cancer, 2013-2020 ($MN)
Table 89 Europe Radiotherapy Market Analysis, by Spine Cancer, 2013-2020 ($MN)
Table 90 Europe Radiotherapy Market Analysis, by Cervical Cancer, 2013-2020 ($MN)
Table 91 APAC Radiotherapy Market Analysis, by Region, 2013-2020 ($MN)
Table 92 APAC Radiotherapy Market Analysis, by Product, 2013-2020 ($MN)
Table 93 APAC Radiotherapy Market Analysis, by Non-Ionizing Radiation, 2013-2020 ($MN)
Table 94 APAC Radiotherapy Market Analysis, by Ionizing Radiation, 2013-2020 ($MN)
Table 95 APAC Radiotherapy Market Analysis, by Particle Radiation, 2013-2020 ($MN)
Table 96 APAC Radiotherapy Market Analysis, by Electron Beams, 2013-2020 ($MN)
Table 97 APAC Radiotherapy Market Analysis, by Proton Beams, 2013-2020 ($MN)
Table 98 APAC Radiotherapy Market Analysis, by Neutron Beams, 2013-2020 ($MN)
Table 99 APAC Radiotherapy Market Analysis, by Carbon Ions, 2013-2020 ($MN)
Table 100 APAC Radiotherapy Market Analysis, by Alpha and Beta Particles, 2013-2020 ($MN)
Table 101 APAC Radiotherapy Market Analysis, by Photon Radiations, 2013-2020 ($MN)
Table 102 APAC Radiotherapy Market Analysis, by Gamma Rays, 2013-2020 ($MN)
Table 103 APAC Radiotherapy Market Analysis, by X-rays, 2013-2020 ($MN)
Table 104 APAC Radiotherapy Market Analysis, by Technology, 2013-2020 ($MN)
Table 105 APAC Radiotherapy Market Analysis, by Intensity Modulated Radiation Therapy (IMRT), 2013-2020 ($MN)
Table 106 APAC Radiotherapy Market Analysis, by 3-D Conformal Radiotherapy (3D CRT), 2013-2020 ($MN)
Table 107 APAC Radiotherapy Market Analysis, by Proton Beam Therapy, 2013-2020 ($MN)
Table 108 APAC Radiotherapy Market Analysis, by Stereotactic Technology, 2013-2020 ($MN)
Table 109 APAC Radiotherapy Market Analysis, by Tomotherapy, 2013-2020 ($MN)
Table 110 APAC Radiotherapy Market Analysis, by Adaptive Radiation Therapy, 2013-2020 ($MN)
Table 111 APAC Radiotherapy Market Analysis, by Systemic Radiation Therapy, 2013-2020 ($MN)
Table 112 APAC Radiotherapy Market Analysis, by Application, 2013-2020 ($MN)
Table 113 APAC Radiotherapy Market Analysis, by Lung Cancer, 2013-2020 ($MN)
Table 114 APAC Radiotherapy Market Analysis, by Colorectal Cancer, 2013-2020 ($MN)
Table 115 APAC Radiotherapy Market Analysis, by Prostate Cancer, 2013-2020 ($MN)
Table 116 APAC Radiotherapy Market Analysis, by Breast Cancer, 2013-2020 ($MN)
Table 117 APAC Radiotherapy Market Analysis, by Head and Neck Cancer, 2013-2020 ($MN)
Table 118 APAC Radiotherapy Market Analysis, by Brain Cancer, 2013-2020 ($MN)
Table 119 APAC Radiotherapy Market Analysis, by Spine Cancer, 2013-2020 ($MN)
Table 120 APAC Radiotherapy Market Analysis, by Cervical Cancer, 2013-2020 ($MN)
Table 121 RoW Radiotherapy Market Analysis, by Region, 2013-2020 ($MN)
Table 122 RoW Radiotherapy Market Analysis, by Product, 2013-2020 ($MN)
Table 123 RoW Radiotherapy Market Analysis, by Non-Ionizing Radiation, 2013-2020 ($MN)
Table 124 RoW Radiotherapy Market Analysis, by Ionizing Radiation, 2013-2020 ($MN)
Table 125 RoW Radiotherapy Market Analysis, by Particle Radiation, 2013-2020 ($MN)
Table 126 RoW Radiotherapy Market Analysis, by Electron Beams, 2013-2020 ($MN)
Table 127 RoW Radiotherapy Market Analysis, by Proton Beams, 2013-2020 ($MN)
Table 128 RoW Radiotherapy Market Analysis, by Neutron Beams, 2013-2020 ($MN)
Table 129 RoW Radiotherapy Market Analysis, by Carbon Ions, 2013-2020 ($MN)
Table 130 RoW Radiotherapy Market Analysis, by Alpha and Beta Particles, 2013-2020 ($MN)
Table 131 RoW Radiotherapy Market Analysis, by Photon Radiations, 2013-2020 ($MN)
Table 132 RoW Radiotherapy Market Analysis, by Gamma Rays, 2013-2020 ($MN)
Table 133 RoW Radiotherapy Market Analysis, by X-rays, 2013-2020 ($MN)
Table 134 RoW Radiotherapy Market Analysis, by Technology, 2013-2020 ($MN)
Table 135 RoW Radiotherapy Market Analysis, by Intensity Modulated Radiation Therapy (IMRT), 2013-2020 ($MN)
Table 136 RoW Radiotherapy Market Analysis, by 3-D Conformal Radiotherapy (3D CRT), 2013-2020 ($MN)
Table 137 RoW Radiotherapy Market Analysis, by Proton Beam Therapy, 2013-2020 ($MN)
Table 138 RoW Radiotherapy Market Analysis, by Stereotactic Technology, 2013-2020 ($MN)
Table 139 RoW Radiotherapy Market Analysis, by Tomotherapy, 2013-2020 ($MN)
Table 140 RoW Radiotherapy Market Analysis, by Adaptive Radiation Therapy, 2013-2020 ($MN)
Table 141 RoW Radiotherapy Market Analysis, by Systemic Radiation Therapy, 2013-2020 ($MN)
Table 142 RoW Radiotherapy Market Analysis, by Application, 2013-2020 ($MN)
Table 143 RoW Radiotherapy Market Analysis, by Lung Cancer, 2013-2020 ($MN)
Table 144 RoW Radiotherapy Market Analysis, by Colorectal Cancer, 2013-2020 ($MN)
Table 145 RoW Radiotherapy Market Analysis, by Prostate Cancer, 2013-2020 ($MN)
Table 146 RoW Radiotherapy Market Analysis, by Breast Cancer, 2013-2020 ($MN)
Table 147 RoW Radiotherapy Market Analysis, by Head and Neck Cancer, 2013-2020 ($MN)
Table 148 RoW Radiotherapy Market Analysis, by Brain Cancer, 2013-2020 ($MN)
Table 149 RoW Radiotherapy Market Analysis, by Spine Cancer, 2013-2020 ($MN)
Table 150 RoW Radiotherapy Market Analysis, by Cervical Cancer, 2013-2020 ($MN)

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Hematological Cancers: Analytical Tool

Hematological Cancers: Analytical Tool

  • $ 11505
  • Industry report
  • August 2016
  • by Bioseeker

Analytical Tools are cancer area specific intelligence and surveillance toolkits within a select number of hot, emerging cancer therapy areas. They are designed to empower biotech/pharma professionals ...

Frontier Pharma: Glioblastoma Multiforme - Cancer Immunotherapies Dominate First-in-Class Product Innovation

Frontier Pharma: Glioblastoma Multiforme - Cancer Immunotherapies Dominate First-in-Class Product Innovation

  • $ 6995
  • Industry report
  • September 2016
  • by GBI Research

Frontier Pharma: Glioblastoma Multiforme - Cancer Immunotherapies Dominate First-in-Class Product Innovation Summary Glioblastoma multiforme (GBM) is a grade IV tumor that arises from astrocytes. It is ...

Drugs and Diagnostics for Hematological Disorders: Global Markets

Drugs and Diagnostics for Hematological Disorders: Global Markets

  • $ 6650
  • Industry report
  • September 2016
  • by BCC Research

Use this report to: - Receive detailed information regarding screening, testing and treatment options for hematological disorders and blood cancer. - Learn about the types of diagnostic and treatment ...

Lung Cancer: Analytical Tool

August 2016 $ 8096

Ovarian Cancer: Analytical Tool

August 2016 $ 8096

Renal Cancer: Analytical Tool

August 2016 $ 8096

Bladder Cancer: Analytical Tool

August 2016 $ 8096

ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.